Susquehanna Fundamental Investments’s Clovis Oncology, Inc. CLVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-115,299
| Closed | -$137K | – | 1589 |
|
|
2022
Q3 | $137K | Buy |
+115,299
| New | +$137K | ﹤0.01% | 1302 |
|
|
2022
Q1 | $519K | Sell |
256,919
-43,284
| -14% | -$87.4K | 0.01% | 1071 |
|
|
2021
Q4 | $814K | Buy |
300,203
+115,299
| +62% | +$313K | 0.02% | 729 |
|
|
2021
Q3 | $825K | Buy |
+184,904
| New | +$825K | 0.02% | 955 |
|
|
2021
Q2 | – | Sell |
-115,628
| Closed | -$812K | – | 1829 |
|
|
2021
Q1 | $812K | Buy |
+115,628
| New | +$812K | 0.01% | 965 |
|
|
2020
Q4 | – | Sell |
-29,300
| Closed | -$171K | – | 1654 |
|
|
2020
Q3 | $171K | Hold |
29,300
| – | – | 0.01% | 1221 |
|
|
2020
Q2 | $198K | Buy |
+29,300
| New | +$198K | 0.01% | 840 |
|